|
May 3
|
Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
|
|
Apr 26
|
Gossamer Bio Decline Means Insider Profits Down To US$17k
|
|
Mar 13
|
13 Best Biotech Stocks To Buy Under $20
|
|
Mar 12
|
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
|
|
Mar 7
|
Should You Buy Gossamer Bio (GOSS) After Golden Cross?
|
|
Mar 5
|
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
|
|
Dec 5
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
|
Dec 5
|
Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
|
|
Nov 29
|
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
|
|
Jul 20
|
Gossamer Bio Announces $212 Million Private Placement Financing
|